MedTrans Go key facts
- Developer of a B2B healthcare appointment optimization platform designed to solve the problems of medical appointment cancellations in the US.
- It has raised $6.5M across 2 recorded rounds; the latest was Seed Round ($2.9M) in Sep 2022.
- Notable investors include Google for Startups, Start Path, Morgan Stanley, Morgan Stanley Inclusive Ventures Lab, TiE Atlanta Angels — 8 tracked in total.
- MedTrans Go has filed 3 Form Ds with the SEC since 2021, most recently Jan 2024 ($2.9M sold to 20 investors).
- Status: Privately Held (backing).
- ·Watch MedTrans Go: the Monday email on marks, rounds and moves
MedTrans Go funding rounds
2 roundsHow much has MedTrans Go raised?
MedTrans Go has raised $6.5 million across 2 recorded rounds since 2021. The largest was a $2.9 million seed round in Sep 2022.
MedTrans Go has filed 3 Form Ds with the SEC since 2021, most recently in Jan 2024 ($2.9 million sold to 20 investors).
MedTrans Go investors
8 investors are on record for MedTrans Go, including Google for Startups, Start Path, Morgan Stanley and Morgan Stanley Inclusive Ventures Lab. The seed round in Sep 2022 drew 20 investors.
About MedTrans Go
Developer of a B2B healthcare appointment optimization platform designed to solve the problems of medical appointment cancellations in the US. The company's tech-enabled portal provides healthcare facilities access to a customizable suite of services to address the root causes of their appointment cancellations in one integrated digital platform, enabling medical practices, hospitals and facilities with services in medical transportation, interpretation, home health care, delivery and more for their patients.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2017
- Employees
- 31
- Website
- medtransgo.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
MedTrans Go doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.